Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trial.
The Journal of pediatrics
In the PDA-TOLERATE trial, persistent (even for several weeks) moderate to large patent ductus arteriosus (PDA) was not associated with an increased risk of BPD when the infant requiredHowever, in infants requiring intubation for ≥10 days, prolonged PDA exposure (≥11 days) was associated with an increased risk of moderate/severe BPD.
Women & Children
Clyman, Ronald I; Kaempf, Joseph; Liebowitz, Melissa; Erdeve, Omer; Bulbul, Ali; Håkansson, Stellan; Lindqvist, Johanna; Farooqi, Aijaz; Katheria, Anup; Sauberan, Jason; Singh, Jaideep; Nelson, Kelly; Wickremasinghe, Andrea; Dong, Lawrence; Hassinger, Denise C; Aucott, Susan W; Hayashi, Madoka; Heuchan, Anne Marie; Carey, William A; Derrick, Matthew; Fernandez, Erika; Sankar, Meera; Leone, Tina; Perez, Jorge; Serize, Arturo; and PDA-TOLERATE Trial Investigators, "Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trial." (2020). Articles, Abstracts, and Reports. 3790.